Response Genetics, Inc
RGDXQ
$0.00
$0.000.00%
OTC PK
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Net Income | -32.83% | -70.80% | -152.83% | -211.67% | -96.10% |
| Total Depreciation and Amortization | 15.72% | 30.74% | 42.89% | 46.78% | 40.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.20% | 84.19% | 182.92% | 141.67% | 110.17% |
| Change in Net Operating Assets | -115.66% | -198.78% | -24.29% | -15.16% | -22.23% |
| Cash from Operations | -50.35% | -120.38% | -66.18% | -121.25% | -59.55% |
| Capital Expenditure | 96.14% | 92.06% | 60.68% | -119.28% | -147.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 79.10% | 69.84% | 62.25% | 69.28% | 64.61% |
| Cash from Investing | 92.19% | 87.36% | 61.16% | 13.69% | 0.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 9.50% | 10.42% | -12.06% | -19.31% | -30.22% |
| Issuance of Common Stock | -99.92% | -99.65% | 158.21% | -26.22% | -26.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 54.63% | 32.17% | 763.29% | -19.75% | -25.27% |
| Foreign Exchange rate Adjustments | 107.56% | 314.29% | -1,278.95% | -651.11% | -981.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.68% | -563.69% | 121.92% | -212.82% | -230.21% |